These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35609442)

  • 1. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: A systematic literature review.
    Schmitt M; Menoux I; Chambrelant I; Hild C; Petit T; Mathelin C; Noël G
    Transl Oncol; 2022 Aug; 22():101456. PubMed ID: 35609442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
    Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W
    Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypofractionated Radiotherapy With Simultaneous-integrated Boost After Breast-conserving Surgery Compared to Standard Boost-applications Using Helical Tomotherapy With TomoEdge.
    Zwicker F; Hoefel S; Kirchner C; Huber PE; Debus J; Schempp M
    Anticancer Res; 2021 Apr; 41(4):1909-1920. PubMed ID: 33813396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study on hypofractionated whole-breast irradiation with sequential or simultaneous integrated boost on different positions after breast-conserving surgery.
    Yu T; Li Y; Sun T; Xu M; Wang W; Shao Q; Zhang Y; Li J; Yu J
    Sci Rep; 2021 Sep; 11(1):18017. PubMed ID: 34504253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer.
    Montero A; Ciérvide R; Cañadillas C; Álvarez B; García-Aranda M; Alonso R; López M; Chen-Zhao X; Alonso L; Valero J; Sánchez E; Hernando O; García de Acilu P; Fernandez-Letón P; Rubio C
    Clin Transl Radiat Oncol; 2023 Jul; 41():100651. PubMed ID: 37388711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity.
    Linares I; Tovar MI; Zurita M; Guerrero R; Expósito M; Del Moral R
    Clin Breast Cancer; 2016 Aug; 16(4):262-8. PubMed ID: 26454613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Heart and Lung Doses According to Tumor Bed Boost Techniques in Early-Stage Left-Sided Breast Cancer: Simultaneous Integrated Boost versus Sequential Boost.
    Kim M; Lee NK; Lee S; Hwang J
    Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
    King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
    Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer.
    Krug D; Köder C; Häfner MF; Arians N; Harrabi SB; Koerber SA; Forster T; Schlampp I; Sohn C; Heil J; Hof H; Hörner-Rieber J; Debus J
    Radiat Oncol; 2020 Oct; 15(1):235. PubMed ID: 33050920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials.
    Pfaffendorf C; Vonthein R; Krockenberger-Ziegler K; Dellas K; Schreiber A; Uhlemann D; Dinges S; Würschmidt F; Andreas P; Weinstrauch E; Eilf K; Rades D; Höller U; Combs SE; Kazmierczak R; Fehlauer F; Schreck U; Zimmer J; Dunst J; Krug D
    Breast; 2022 Aug; 64():136-142. PubMed ID: 35691249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary result.
    Lee HH; Hou MF; Chuang HY; Huang MY; Tsuei LP; Chen FM; Ou-Yang F; Huang CJ
    Breast; 2015 Oct; 24(5):656-60. PubMed ID: 26371691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy.
    De Santis MC; Bonfantini F; Di Salvo F; Dispinzieri M; Mantero E; Soncini F; Baili P; Sant M; Bianchi G; Maggi C; Di Cosimo S; Agresti R; Pignoli E; Valdagni R; Lozza L
    Breast; 2016 Oct; 29():90-5. PubMed ID: 27476083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
    Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
    Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated whole breast irradiation in association with hypofractionated or normofractionated boost to the tumor bed in early breast cancer: tolerance and efficacy analysis.
    Oses G; Barreto TD; Cases C; Muñoz-Guglielmetti D; Antelo G; Mollà M
    Clin Transl Oncol; 2023 Aug; 25(8):2419-2426. PubMed ID: 36947361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly concomitant boost in adjuvant radiotherapy for patients with early breast cancer: preliminary results on feasibility.
    Corvò R; Giudici S; Maggio F; Bevegni M; Sampietro C; Lucido MR; Orsatti M
    Tumori; 2008; 94(5):706-11. PubMed ID: 19112945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated intensity-modulated simultaneous integrated boost and image-guided radiotherapy in the treatment of high-risk prostate cancer patients: a preliminary report on acute toxicity.
    Valeriani M; Carnevale A; Osti MF; Minniti G; De Sanctis V; Agolli L; Bracci S; Enrici RM
    Tumori; 2013; 99(4):474-9. PubMed ID: 24326835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer.
    Cante D; Petrucci E; Sciacero P; Piva C; Ferrario S; Bagnera S; Patania S; Mondini G; Pasquino M; Casanova Borca V; Vellani G; La Porta MR; Franco P
    Med Oncol; 2017 Sep; 34(9):152. PubMed ID: 28776318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India.
    Mondal D; Julka PK; Sharma DN; Jana M; Laviraj MA; Deo SV; Roy S; Guleria R; Rath GK
    J Egypt Natl Canc Inst; 2017 Mar; 29(1):39-45. PubMed ID: 28343538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.